Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AFFYMETRIX (AFFX) -- Ignore unavailable to you. Want to Upgrade?

To: semi_infinite who wrote (910)	7/23/1999 11:20:00 AM
From: LLCF	Read Replies (1) \| Respond to of 1728

<The federal health systems and national research centers set the future protocols for gene testing. By their recent announcements it is apparent that AFFX has become the de-facto monopoly for gene chips and standards. > But they're saying much more than "gene testing"... it looks to me that they are talking IT as well. This is smack in INCY land? : "<Affymetrix has developed and intends to establish its GeneChip system as the platform of choice for acquiring, analyzing and managing complex genetic information" IMO there is plenty left "up in the air". DAK